Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,613 | 392 | 89.9% |
| Education | $733.04 | 15 | 10.0% |
| Entertainment | $13.36 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $1,936 | 105 | $0 (2024) |
| Janssen Biotech, Inc. | $1,076 | 56 | $0 (2023) |
| PFIZER INC. | $561.34 | 38 | $0 (2024) |
| Sumitomo Pharma America, Inc. | $417.10 | 27 | $0 (2024) |
| Boston Scientific Corporation | $282.57 | 10 | $0 (2023) |
| Merck Sharp & Dohme LLC | $270.33 | 16 | $0 (2024) |
| UROVANT SCIENCES INC | $252.52 | 15 | $0 (2022) |
| DENTSPLY IH Inc. | $226.82 | 17 | $0 (2021) |
| ABBVIE INC. | $187.78 | 12 | $0 (2023) |
| Janssen Products, LP | $184.00 | 2 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $455.08 | 26 | Sumitomo Pharma America, Inc. ($223.43) |
| 2023 | $731.60 | 38 | Sumitomo Pharma America, Inc. ($193.67) |
| 2022 | $1,459 | 69 | Astellas Pharma US Inc ($221.36) |
| 2021 | $1,208 | 68 | Astellas Pharma US Inc ($371.44) |
| 2020 | $773.76 | 37 | Astellas Pharma US Inc ($394.83) |
| 2019 | $838.55 | 55 | Janssen Biotech, Inc. ($234.22) |
| 2018 | $691.07 | 46 | Astellas Pharma US Inc ($202.34) |
| 2017 | $1,203 | 69 | Astellas Pharma US Inc ($412.16) |
All Payment Transactions
408 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Olympus America Inc. | iTIND System (Device) | Food and Beverage | In-kind items and services | $26.69 | General |
| Category: Urology Gynecology | ||||||
| 12/10/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $18.85 | General |
| Category: ONCOLOGY | ||||||
| 12/05/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $16.10 | General |
| Category: UROLOGY | ||||||
| 11/12/2024 | Axonics, Inc. | Axonics (Device) | Food and Beverage | In-kind items and services | $17.86 | General |
| Category: Urology | ||||||
| 10/25/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $17.28 | General |
| Category: UROLOGY | ||||||
| 10/16/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $17.16 | General |
| Category: UROTHELIAL CANCER | ||||||
| 10/10/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $15.23 | General |
| Category: UROLOGY | ||||||
| 09/10/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $12.77 | General |
| Category: UROLOGY | ||||||
| 09/10/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $3.59 | General |
| Category: UROLOGY | ||||||
| 08/21/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $19.99 | General |
| Category: UROLOGY | ||||||
| 07/30/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $24.28 | General |
| Category: ONCOLOGY | ||||||
| 07/23/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $9.57 | General |
| Category: UROLOGY | ||||||
| 06/12/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $12.67 | General |
| Category: UROLOGY | ||||||
| 05/24/2024 | Smith+Nephew, Inc. | GRAFIX PL (Medical Supply) | Food and Beverage | In-kind items and services | $28.80 | General |
| Category: Other Advanced Wound Management | ||||||
| 05/22/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $19.13 | General |
| Category: UROLOGY | ||||||
| 05/02/2024 | Provepharm Inc. | BLUDIGO (Drug) | Entertainment | In-kind items and services | $13.36 | General |
| Category: MARKER DYE | ||||||
| 04/16/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $12.99 | General |
| Category: UROLOGY | ||||||
| 04/09/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $19.19 | General |
| Category: UROLOGY | ||||||
| 03/19/2024 | Smith+Nephew, Inc. | GRAFIX PL (Medical Supply), STRAVIX PL | Food and Beverage | In-kind items and services | $17.38 | General |
| Category: Other Advanced Wound Management | ||||||
| 03/12/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $13.69 | General |
| Category: UROLOGY | ||||||
| 03/05/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $12.97 | General |
| Category: HORMONE THERAPY | ||||||
| 02/15/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $17.47 | General |
| Category: UROLOGY | ||||||
| 02/14/2024 | DENTSPLY IH AB | LOFRIC (Device) | Food and Beverage | In-kind items and services | $23.76 | General |
| Category: Medical Urology | ||||||
| 02/13/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $22.79 | General |
| Category: Biological | ||||||
| 01/18/2024 | PFIZER INC. | PREMARIN (Drug), ESTRING, DUAVEE | Food and Beverage | In-kind items and services | $20.72 | General |
| Category: WOMENS HEALTH | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 793 | 878 | $193,742 | $62,956 |
| 2022 | 10 | 908 | 1,118 | $196,483 | $68,419 |
| 2021 | 13 | 877 | 1,129 | $187,936 | $66,959 |
| 2020 | 10 | 905 | 1,214 | $174,927 | $61,973 |
All Medicare Procedures & Services
51 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 209 | 256 | $36,608 | $17,060 | 46.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 179 | 179 | $45,108 | $14,621 | 32.4% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 36 | 37 | $15,170 | $6,784 | 44.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 43 | 47 | $10,011 | $4,347 | 43.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 33 | 35 | $11,725 | $3,462 | 29.5% |
| 52356 | Crushing of stone of ureter with insertion of stent using an endoscope | Facility | 2023 | 11 | 11 | $8,756 | $3,453 | 39.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 94 | 97 | $10,121 | $3,347 | 33.1% |
| 55700 | Biopsy of prostate gland | Facility | 2023 | 19 | 19 | $5,818 | $1,773 | 30.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 11 | 11 | $4,796 | $1,500 | 31.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2023 | 23 | 23 | $5,796 | $1,494 | 25.8% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2023 | 11 | 12 | $10,975 | $1,201 | 10.9% |
| 52310 | Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | Facility | 2023 | 11 | 11 | $4,733 | $1,107 | 23.4% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Facility | 2023 | 16 | 16 | $6,732 | $937.80 | 13.9% |
| 76942 | Ultrasonic guidance for needle placement | Facility | 2023 | 17 | 17 | $4,624 | $408.34 | 8.8% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 32 | 53 | $2,173 | $397.39 | 18.3% |
| 74420 | Imaging of urinary tract following injection of a contrast agent | Facility | 2023 | 17 | 20 | $7,740 | $384.01 | 5.0% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 19 | 22 | $1,430 | $374.64 | 26.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 12 | 12 | $1,426 | $305.80 | 21.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 646 | 834 | $56,712 | $37,397 | 65.9% |
| 52356 | Crushing of stone of ureter with insertion of stent using an endoscope | Facility | 2022 | 18 | 19 | $18,174 | $6,390 | 35.2% |
| 52005 | Insertion of tube into ureter using an endoscope through bladder area | Facility | 2022 | 45 | 46 | $35,420 | $4,490 | 12.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 39 | 39 | $5,304 | $3,567 | 67.2% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2022 | 17 | 30 | $29,925 | $3,405 | 11.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 41 | 43 | $4,300 | $3,180 | 74.0% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 23 | 26 | $8,710 | $2,764 | 31.7% |
About Dr. Michael Martynik, MD
Dr. Michael Martynik, MD is a Urology healthcare provider based in Meadville, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1972519072.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Martynik, MD has received a total of $7,359 in payments from pharmaceutical and medical device companies, with $455.08 received in 2024. These payments were reported across 408 transactions from 47 companies. The most common payment nature is "Food and Beverage" ($6,613).
As a Medicare-enrolled provider, Martynik has provided services to 3,483 Medicare beneficiaries, totaling 4,339 services with total Medicare billing of $260,308. Data is available for 4 years (2020–2023), covering 51 distinct procedure/service records.
Practice Information
- Specialty Urology
- Other Specialties Urology
- Location Meadville, PA
- Active Since 07/31/2006
- Last Updated 02/16/2023
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1972519072
Products in Payments
- XTANDI (Drug) $1,413
- GEMTESA (Drug) $608.61
- ERLEADA (Drug) $447.60
- Myrbetriq (Drug) $434.75
- ZYTIGA (Drug) $367.26
- Erleada (Drug) $334.39
- KEYTRUDA (Biological) $256.67
- MYRBETRIQ (Drug) $230.32
- LoFric (Device) $226.82
- ORGOVYX (Drug) $168.60
- Nubeqa (Drug) $157.28
- OPDIVO (Biological) $149.18
- LITHOCLAST (Device) $125.00
- Xtandi (Drug) $113.56
- LYNPARZA (Drug) $100.85
- ELIGARD (Drug) $93.85
- rezum Generator (Device) $73.50
- Prolia (Biological) $64.31
- CALDOLOR (Drug) $63.41
- Androgel (Drug) $60.57
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.